SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950123-09-020939
Filing Date
2009-07-08
Accepted
2009-07-08 17:25:51
Documents
2
Effectiveness Date
2009-07-08

Document Format Files

Seq Description Document Type Size
1 CORNERSTONE THERAPEUTICS INC. b76158cte8vk.htm DEFA14A 12797
2 PRESS RELEASE ISSUED BY CORNERSTONE THERAPEUTICS INC. ON JULY 8, 2009 b76158ctexv99w1.htm EX-99.1 5500
  Complete submission text file 0000950123-09-020939.txt   19837
Mailing Address 1255 CRESCENT GREEN DRIVE SUITE 250 CARY NC 27518
Business Address 1255 CRESCENT GREEN DRIVE SUITE 250 CARY NC 27518 919-678-6611
CORNERSTONE THERAPEUTICS INC (Filer) CIK: 0001145404 (see all company filings)

IRS No.: 043523569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-50767 | Film No.: 09935653
SIC: 2834 Pharmaceutical Preparations